Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

arrow miss target fail attempt try
Pharma

BMS details Krazati confirmatory fail in colorectal cancer

BMS has detailed a phase 3 flop for KRAS inhibitor Krazati's smaller-opportunity accelerated FDA approval in colorectal cancer.
Fraiser Kansteiner Jul 7, 2026 10:46am
A chessboard with blocks that read MA

Vertex to pay $10B for Crinetics in its largest-ever deal

Jul 7, 2026 8:08am
Amgen

NEJM retracts article on pivotal study for Amgen’s Tavneos

Jun 30, 2026 10:57am
Epkinly

AbbVie, Genmab's Epkinly redeems itself in DLBCL

Jun 30, 2026 9:50am
BeOne

BeOne’s Brukinsa hits goal in lymphoma confirmatory trial

Jun 30, 2026 6:00am
Ebola Ebola test
Favicon Fierce Biotech

Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO

Jun 24, 2026 3:03pm